Viewing StudyNCT00048503



Ignite Creation Date: 2024-05-05 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00048503
Status: COMPLETED
Last Update Posted: 2010-04-27
First Post: 2002-11-01

Brief Title: Study of Tipifarnib as Postconsolidation Therapy for Acute Myeloid Leukemia in Patients 60 Years and Older
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Keywords:
Name View
Tipifarnib View
Zarnestra View
Acute myeloid leukemia View